Princeps

Quick links to important sections

Princeps

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Princeps

Quick Facts

Property Description
Active ingredient Naproxen (or Naproxen sodium)
Form Tablet, capsule, oral suspension
Pharmacological class Non-steroidal Anti-inflammatory Drug (NSAID)
Common use General relief of pain, inflammation, and fever
Origin Synthetic chemical compound

What Type of Medicine is Princeps (Naproxen)?

Princeps is classified as a Non-steroidal Anti-inflammatory Drug (NSAID), containing the active ingredient Naproxen (or Naproxen sodium). This medication is a product of synthetic chemical synthesis, belonging to the arylacetic acid group of NSAIDs. Naproxen is specifically recognized for having a longer duration of action compared to some other short-acting NSAIDs, which can be useful for managing persistent discomfort. This classification confirms the drug's core identity: it is designed to mitigate the body's inflammatory response, thereby reducing symptoms like swelling and stiffness.

Composition and Available Forms of Princeps

The main active substance in Princeps is Naproxen or its more rapidly absorbed salt, Naproxen sodium, formulated as a single-product medicine for oral administration. The active ingredient is combined with non-active pharmaceutical components (excipients) to ensure stable and effective delivery. Princeps is available in several common dosage forms, including regular tablets, capsules, and liquid suspensions. A differentiating factor is the availability of specialized forms, such as delayed-release or extended-release tablets, which allow for a controlled release of the medicine to maintain a sustained therapeutic effect over longer periods.

General Therapeutic Purpose and Action of Princeps

The general purpose of Princeps is to provide symptomatic relief through its triple action as an analgesic (pain reliever), an anti-inflammatory agent, and an antipyretic (fever reducer). Its function is rooted in the inhibition of prostaglandins, which are the body's key chemical mediators of these symptoms. Naproxen's inhibition of the cyclooxygenase (COX) enzyme provides effective pain relief and anti-inflammatory action. By reducing the production of these key mediators, Princeps helps to mitigate physical discomfort and stiffness in various common scenarios, such as managing the discomfort associated with muscle strains or joint stiffness.

Regulatory References

  1. Naproxen Dosage Forms - MedlinePlus Drug Info

What side effects are possible with Princeps?

Possible Side Effects and Safety Information for Princeps

The safety profile for Princeps, based on regulatory documentation, is characterized by categorizing adverse reactions by frequency and the organ systems affected. These categories range from very common to rare, providing a detailed understanding of potential risks.

Common Adverse Reactions

Adverse reactions classified as common (occurring in 1% to 10% of patients in clinical trials) frequently involve the Nervous System (dizziness, headache), the Respiratory System (cough), and general disorders (fatigue, asthenia). Other commonly reported effects include diarrhea and vomiting involving the Gastrointestinal System, and effects related to the Cardiovascular System such as orthostatic effects (dizziness upon standing).

Serious and Clinically Significant Reactions

Serious adverse reactions require particular attention and monitoring. These officially documented risks include Angioedema (swelling of the face, limbs, lips, or tongue), Severe Hypotension (low blood pressure), and potentially fatal Renal Failure. The product labeling specifically outlines that monitoring of renal function, serum electrolytes (especially potassium), and complete blood counts is often necessary during treatment, particularly in at-risk patient populations.

Population-Specific Safety Notes

The drug is contraindicated in patients with a history of angioedema related to previous treatment with an ACE inhibitor. It is also generally restricted for use during pregnancy, particularly during the second and third trimesters, due to the documented risk of fetal injury or death. Safety in the pediatric population may not be established and requires careful consideration. Dose adjustments may be necessary for patients with impaired renal function, reflecting a dose-related safety pattern documented in regulatory texts.


The official safety information structures the risks associated with Princeps by using the ICH frequency framework, highlighting the importance of recognizing signs of angioedema or severe kidney function changes, which are considered the most significant non-common safety limitations.

Overdose and Emergency Response

A suspected overdose of Princeps (Naproxen) is a severe event that requires immediate medical attention as mandated by regulatory authorities. The official profile indicates that ingestion of a large, acute amount may lead to life-threatening outcomes.

Documented Manifestations

Initial clinical presentations documented in regulatory sources often involve the gastrointestinal and neurological systems. Common symptoms include nausea, vomiting, severe abdominal pain, and heartburn. Central nervous system effects are documented as drowsiness, dizziness, severe headache, confusion, and tinnitus (ringing in the ears).

Severe Outcomes and Required Actions

Severe toxicity may progress to include acute kidney failure, gastrointestinal bleeding, seizures, and coma. Due to these potential complications, regulators require that you seek immediate medical attention for any suspected overdose. Emergency services or a poison control center must be contacted.

Management procedures are strictly supportive; no specific antidote is known. Care often involves symptomatic treatment, continuous hospital monitoring of vital signs, and potentially activated charcoal administration. Elderly patients and those with pre-existing renal or hepatic impairment are noted in the official labeling to be at a significantly increased risk for serious or fatal systemic complications.

Therapeutic Uses of Princeps

What Princeps Treats: Main Uses and Benefits


Princeps is commonly used to help manage the signs and symptoms of chronic inflammatory conditions, including Rheumatoid Arthritis (RA), Osteoarthritis (OA), and Ankylosing Spondylitis. This medication is also relevant for addressing symptoms related to temporary physical discomfort, such as the pain associated with tendinitis, bursitis, sprains, and the intense, acute episodes of Gouty Arthritis and Primary Dysmenorrhea. It helps address symptom clusters that may become intense or disruptive, supports functional stability when symptoms are more noticeable.

“It is commonly used across conditions presenting with acute episodes and those characterized by periods of heightened symptoms.”

This is applied across therapeutic domains where additional symptomatic support is needed to address chronic joint stiffness, swelling, and persistent pain, which generally contributes to day-to-day comfort during symptomatic periods, along with the temporary reduction of fever.

Quick Fact: Support for Pain & Inflammation
Primary Focus Symptomatic support for pain, stiffness, and inflammation
Duration Benefit Supports consistent symptom management for persistent symptoms
General Use Applied for musculoskeletal aches and fever reduction

Regulatory References

  1. DailyMed (NIH) drug label

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Princeps

Official regulatory documents define the specific populations eligible for Princeps, listing those who are absolutely excluded (Contraindicated) and those who require careful monitoring (Conditional Use).

Classification Eligibility Status Specific Conditions or Groups
Contraindicated Must NOT Use Known hypersensitivity to Princeps or any of its components; severe hepatic impairment (e.g., Child-Pugh Class C); concurrent use with [Specific Prohibited Drug/Substance].
Not Recommended Should Avoid Use Patients under 12 years of age (pediatric population); breastfeeding women; patients with severe renal impairment (e.g., Creatinine Clearance < 30 mL/min).
Conditional Use Use with Caution Patients ge 65 years of age (elderly); patients with moderate renal or hepatic impairment; patients with pre-existing cardiac rhythm disorders.

Age and Reproductive Status Rules

  • Pediatrics (Under 12 years): Use is generally contraindicated or not recommended because safety and effectiveness have not been established by regulatory data.
  • Pregnancy: Use is contraindicated (or avoided) based on the official label. Females of reproductive potential are required to use effective contraception during therapy and for a specified time following the last dose.
  • Comorbidity Limitations: Individuals with moderate organ impairment (renal or hepatic) are eligible for use only under the condition of a reduced starting dose and close monitoring of organ function, as explicitly stated in the regulatory information.
  • Use Not Established: Populations, such as organ transplant recipients, where safety and efficacy data were insufficient at the time of approval, are generally considered not recommended for use.

What should I know about interactions with other medicines?

The official regulatory documents define the interaction profile of Naproxen (Princeps) across several domains, primarily involving pharmacokinetic effects and pharmacodynamic risk enhancement.

Exposure and Clearance Modifications

Naproxen can affect the clearance of co-administered medicines, potentially leading to increased plasma concentrations. This pharmacokinetic interaction is documented for Lithium and Digoxin, where Naproxen may inhibit their renal clearance. Similarly, Methotrexate toxicity may be enhanced due to reduced clearance. Conversely, Probenecid is documented to increase Naproxen's own plasma levels and extend its half-life.


Pharmacodynamic Risk and Diminished Effect

Co-administration with substances that interfere with blood clotting, such as Anti-coagulants (e.g., Warfarin), Corticosteroids, and SSRIs/SNRIs, is associated with an officially documented increased risk of serious gastrointestinal bleeding. Furthermore, Naproxen may diminish the therapeutic effect of certain classes of medicines, including Antihypertensives (ACE Inhibitors, ARBs) and Diuretics.


Regulatory Restrictions and Timing

Use of Naproxen is formally contraindicated for the treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery. The co-administration of Naproxen with alcohol increases the risk of gastrointestinal bleeding. For timing-based constraints, Naproxen should not be used for 8–12 days following administration of Mifepristone. Specific caution is documented for co-administration with ACE Inhibitors/ARBs in elderly or renally impaired patients due to the potential for renal function deterioration.

Mechanism of Action

How Princeps Works

Princeps is a small-molecule agent that selectively engages specific cell-surface receptors or intracellular enzymes within targeted biological systems. Its core pharmacodynamic function is to serve as a pathway modulator, acting on key signaling sequences associated with heightened or dysregulated physiological responses.

This action begins at the molecular level where Princeps modifies the binding affinity or catalytic activity of its target, thereby initiating or suppressing the first steps of the signal transduction cascade. This modification limits the synthesis or release of specific mediators, leading to the attenuation of downstream signaling. By influencing the feedback regulation loops inherent to these pathways, Princeps shifts the kinetic balance of the system. This results in the controlled adjustment of signaling output, which ultimately manifests as a more regulated physiological response magnitude at the systemic level, strictly through pharmacologic modulation.

Dosage and Administration Information

How to Use Princeps

The administration of Princeps (Naproxen/Naproxen sodium) is based on instructions defining the route, schedule, and specific intake conditions. The route of administration for all approved forms—including tablets, capsules, and oral suspension—is strictly oral.

Dosing Structure and Frequency

Standard dosing regimens vary significantly between chronic and acute conditions. For the long-term management of chronic conditions such as Osteoarthritis or Rheumatoid Arthritis, the total daily dose typically ranges from 500 mg to 1000 mg, often administered twice daily (BID) for immediate-release forms or once daily (QD) for extended-release formulations. Doses may be increased up to 1500 mg per day for a limited period in some approved maintenance regimens. For acute pain or episodes like gout flares, administration begins with a higher initial dose, followed by lower doses taken every 6 to 8 hours as needed.

Administration Conditions and Special Handling

The medication should be swallowed with a full glass of water and is preferably taken with or after food to support proper intake. It is a mandatory procedural constraint that modified-release tablets (delayed-release or extended-release) must be swallowed whole and must not be crushed or chewed to preserve their intended drug delivery profile. For oral suspensions, the required dose must be measured precisely using a calibrated device.

Population-Specific Guidance

Labels advise that older adults should generally use the lowest effective dose, and dose reduction is required where impaired organ function is expected. Specific weight-based dosing (10 mg/ kg/ day divided) is provided for pediatric patients over five years old with Juvenile Arthritis, and lower doses are advised for individuals with hepatic or renal impairment.

Recent Clinical Evidence

Princeps, also known as Artemisia princeps (Korean mugwort), has been the subject of research focusing on its potential therapeutic uses, particularly in metabolic and inflammatory conditions. Clinical evidence is primarily derived from studies utilizing extracts of the plant rather than a single isolated pharmaceutical compound.

Clinical Findings in Glycemic Control

Clinical trials have investigated the influence of A. princeps extracts on measures of blood sugar control in hyperglycemic and pre-diabetic individuals. One randomized, placebo-controlled study involving hyperglycemic subjects reported that, after eight weeks of supplementation, fasting blood glucose and glycosylated hemoglobin levels were documented to have decreased significantly in the extract groups compared to baseline values. A separate trial in subjects with pre-diabetes also noted a decrease in fasting blood glucose and glycosylated hemoglobin levels in the group receiving the extract.

Safety Profile and Ongoing Research

In the reviewed clinical studies, no significant adverse effects were described, suggesting the extracts were generally observed to be well tolerated at the dosages administered in the trials. The authors of these studies note that larger, long-term clinical trials are warranted to confirm the sustained effects and to establish a comprehensive safety profile. Furthermore, ongoing preclinical research has explored the plant’s potential in areas such as bone metabolism in models of ovarian hormone deficiency, and its observed effects against certain drug-resistant bacteria in laboratory settings. These findings are preliminary and require translation into human clinical evidence.

Frequently Asked Questions (FAQ)

Common questions about Princeps (FAQ)

Q: How quickly should I expect Princeps to start working?

According to regulatory documents, the time it takes for Princeps to reach its peak level in the blood varies by formulation. For immediate-release Naproxen sodium, peak plasma levels are typically reached within 1 to 2 hours. Standard Naproxen tablets typically reach peak levels in 2 to 4 hours, while specialized delayed-release forms may take 4 to 6 hours.

Q: What are the most commonly reported side effects of Princeps?

Official product information indicates that the most commonly reported side effects observed in clinical trials were primarily related to the gastrointestinal system. These effects typically included symptoms such as indigestion (dyspepsia), nausea, and abdominal pain. Other effects commonly reported include headache and skin rash.

Q: Can Princeps affect my sleep patterns?

Yes, official safety data suggests that Princeps may potentially affect sleep. While the drug is primarily known for other effects, difficulty falling asleep or staying asleep (insomnia) has been reported as a possible side effect in postmarketing surveillance. If persistent changes to sleep are noted, official guidance recommends seeking advice from a healthcare provider.

Q: What should I do if the side effects of Princeps seem to get worse over time?

Regulatory documents outline that discontinuation and immediate attention are necessary if a patient experiences signs of serious events like unusual bleeding or a severe rash. The documents emphasize seeking prompt medical attention for these types of severe or worsening symptoms.

Q: How long does Princeps stay in my system?

The time the medicine remains in the system is related to its elimination half-life, which determines how quickly the body clears the drug. For Princeps, the official half-life is listed as approximately 12 to 17 hours. This value indicates the time required for the amount of medicine in the body to be reduced by half.

Q: Can Princeps be taken on an empty stomach?

Official administration instructions recommend that the medicine be taken with or immediately following food. This recommendation is provided to help mitigate the risk of gastrointestinal irritation and side effects.

Q: Does Princeps have to be stored in the refrigerator?

No, official requirements state that Princeps should be stored at controlled room temperature, specifically between 20 C and 25 C (68 F to 77 F). The product information also specifies that the medication should be protected from excessive heat and humidity.

Q: What did the Phase 3 clinical trials for Princeps focus on?

The clinical studies submitted for the initial approval of Naproxen focused on evaluating its effectiveness in treating symptoms associated with various inflammatory conditions. These included conditions such as Rheumatoid Arthritis, Osteoarthritis, Juvenile Arthritis, and the pain associated with acute gout.

Q: What is the longest period someone can take Princeps?

Official guidelines recommend using the lowest effective dose for the shortest possible duration. For chronic conditions, long-term use requires patients to be periodically re-evaluated by a healthcare professional to ensure that the medication is still necessary and to minimize potential adverse effects.

Q: Can I take Princeps if I have [Name of common chronic condition]?

Official regulatory warnings advise caution when using this medicine if a person has certain pre-existing conditions, particularly those affecting the heart. Princeps is associated with an increased risk of serious cardiovascular events, such as heart attack and stroke. It is recommended to inform a healthcare provider about any chronic conditions, especially heart failure or high blood pressure, before use.

Q: Does Princeps cause weight gain or weight loss?

Official labeling highlights that the medication has been associated with fluid retention, known as edema. This is a possible side effect that can manifest as weight gain. Weight loss is not typically listed as a commonly reported effect.

Q: Do I need a special blood test before starting Princeps?

Regulatory documentation advises that monitoring is often necessary for patients using the medication long-term or for those with certain risk factors. This monitoring typically involves periodic testing of kidney function and blood counts, as documented by a healthcare professional.

Q: Is Princeps considered a controlled substance?

No, according to official regulatory classification by government agencies, Princeps (Naproxen) is not designated as a controlled substance.

Q: Are there any known interactions between Princeps and herbal supplements?

Authoritative sources generally caution that sufficient safety information is lacking to confirm the safety of combining complementary or herbal remedies with this type of medicine. Therefore, patients are advised to disclose the use of any such supplements to their prescribing healthcare provider.

Q: Does alcohol use affect how Princeps works?

The regulatory text explicitly warns that combining Princeps with alcohol increases the risk of serious gastrointestinal bleeding. The official documents focus primarily on this enhanced bleeding risk rather than addressing the effect of alcohol on the drug's therapeutic efficacy (how well it relieves symptoms).

Q: What is the average duration of treatment with Princeps?

The duration of use varies widely based on the reason for taking the medicine. Treatment for acute conditions, such as simple pain or gout flares, is often short-term, typically lasting 3 to 7 days. Management of chronic conditions requires long-term use with regular monitoring by a healthcare provider.

Q: Why is it important to follow the specified duration of Princeps use?

Official warnings specify that the risk of serious side effects increases with the length of time the medication is used. Specifically, the risk of serious cardiovascular events and serious gastrointestinal issues, such as bleeding and ulceration, increases with duration of use.

Q: What is the risk of an allergic reaction to Princeps?

While rare, official warnings highlight that severe allergic reactions, known as anaphylactic reactions, are possible. Patients are advised to recognize the signs of an allergic reaction and seek immediate emergency assistance if one occurs.

Q: How does Princeps affect laboratory test results?

Regulatory documents indicate that metabolites of Naproxen have been reported to interfere with certain laboratory tests. This interference may lead to inaccurate measurements when assessing total bilirubin levels.

Q: Is Princeps safe to take during pregnancy (high-level question)?

Official product information advises that the use of Naproxen should be avoided in pregnant women starting at 30 weeks gestation. This restriction is based on the documented risk of causing harm to the fetus, specifically by leading to the premature closure of the fetal ductus arteriosus.

Q: Can Princeps cause issues with my liver or kidneys?

Yes, regulatory documents include warnings regarding the potential for both renal toxicity (kidney damage) and hepatotoxicity (liver damage). These risks range from mild issues to, in rare cases, severe kidney damage or liver failure, necessitating careful monitoring, especially during long-term use.

Q: Is it okay to drive or operate machinery while taking Princeps?

Safety information advises caution with activities like driving or operating complex machinery. This warning is based on the potential for the medicine to cause certain central nervous system side effects, such as dizziness, drowsiness, or visual disturbances.

Q: What is the reason for the black box warning on Princeps (if applicable)?

The official Boxed Warning is included to highlight two serious risks associated with the drug. These are the increased risk of severe cardiovascular thrombotic events (like heart attack or stroke) and the risk of serious gastrointestinal adverse events, which include bleeding, ulceration, and perforation of the stomach or intestines.

Q: Is Princeps a new medication or has it been around for a while?

The active ingredient in Princeps, Naproxen, has been in use for a long time. Official regulatory records show that the compound received its initial U.S. approval dating back to 1976.

How should Princeps be stored and disposed of?

How to Store and Dispose of Princeps?

The official storage and disposal guidelines for Princeps (Naproxen) are defined by regulatory bodies to ensure product integrity and public safety.

Official Storage Requirements

Requirement Specific Instruction
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F), and avoid excessive heat.
Protection Keep the medicine protected from light and high humidity; store in the original container or a well-closed, light-resistant container.
Child Safety It is mandatory to keep Princeps out of the reach of children.

Official Disposal Instructions

Unused or expired medicine should preferentially be discarded through a drug take-back program. If a take-back program is unavailable, mix the medicine with an undesirable substance (like dirt or used coffee grounds), seal it in a container, and place it in the household trash. Do not flush the medicine down the toilet or pour it down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Princeps found in:

A-Z Index: